Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/4/25 16:22 | 12/3/25 | SLDB | Health | BioPrd | Biological Products, (No Diag | Howton David T | MA | O | COO | 3 | S.d | -76 | 4.86 | 0 | -16 | 33 | D | |||||||||||||||
12/4/25 16:20 | 12/3/25 | SLDB | Health | BioPrd | Biological Products, (No Diag | Cumbo Alexander | MA | DO | P,CEO | 3 | S.d | -162 | 4.88 | 0 | -33 | 81 | D | |||||||||||||||
12/4/25 16:19 | 12/3/25 | SLDB | Health | BioPrd | Biological Products, (No Diag | Hanrahan Jessie | MA | O | Chief Re | 3 | S.d | -61 | 5.01 | 0 | -12 | 27 | D | |||||||||||||||
12/4/25 16:17 | 12/3/25 | SLDB | Health | BioPrd | Biological Products, (No Diag | Herzich Paul | MA | O | CTO | 3 | S.d | -40 | 4.90 | 0 | -8 | 27 | D | |||||||||||||||
11/13/25 16:05 | 11/10/25 | SLDB | Health | BioPrd | Biological Products, (No Diag | Ganot Ilan | MA | D | 4 | S.d | -25 | 4.08 | 0 | -6 | 133 | D | ||||||||||||||||
10/21/25 16:05 | 10/20/25 | SLDB | Health | BioPrd | Biological Products, (No Diag | Brooks Gabriel | MA | O | Chief Me | 3 | S.d | -49 | 5.42 | 0 | -9 | 34 | D | |||||||||||||||
2/18/25 16:05 | 2/14/25 | SLDB | Health | BioPrd | Biological Products, (No Diag | Tan Kevin | MA | O | CFO,Trea | 2 | S.d | -28 | 3.92 | 0 | -7 | 32 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |